EXHIBIT 23.2

                          INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this Registration Statement of
AVANIR Pharmaceuticals on Form S-3 of our report dated December 19, 2003,
appearing in the Annual Report on Form 10-K of AVANIR Pharmaceuticals for the
year ended September 30, 2003 and to the reference to us under the heading
"Experts" in the Prospectus, which is part of this Registration Statement.

/s/ Deloitte & Touche LLP

San Diego, California
December 31, 2003